APP and Alzheimer disease: Similarly, the binding of miR-101, miR-31, and miR-17 to the 3′-UTR of the APP mRNA resulted in decreased level of APP in patients with AD (Barros-Viegas et al., 2020[14]; Kou et al., 2020[68]).